Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has issued an update.
Vita Life Sciences has issued its FY2025 guidance, projecting significant sales growth to $91m-$92m, up from $79.5m in FY2024, and a pre-tax profit increase to $13.2m-$13.7m. The growth is driven by robust performance in Malaysia and Singapore, with anticipated 30% revenue growth, and steady contributions from the Australian market. However, export sales to China are expected to fall short of initial expectations due to trade partner transitions. The company is committed to investing in brand development and market positioning to support long-term growth, focusing on core markets and exploring new opportunities in Vietnam and China.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of vitamins and supplements. The company has a strong market presence in Malaysia, Australia, and Singapore, with emerging opportunities in Vietnam and China.
Average Trading Volume: 13,205
Technical Sentiment Signal: Buy
Current Market Cap: A$132.2M
See more data about VLS stock on TipRanks’ Stock Analysis page.